Northwestern is part of the Impact of Genomic Variation on Function (IGVF) Consortium, a $185 million National Institutes of Health (NIH) project that will explore the millions of genetic variants that cause disease around the world.
Northwestern Medicine is part of the research team on a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, according to a new study, the first to show the process beginning so early.
Northwestern Medicine physician-scientist Amy Heimberger, MD, has been named by President Biden to the National Cancer Advisory Board, which plays an important role in setting the course for the nation’s cancer research programs.
Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, reducing muscle scarring in an animal model of the disease.
A biomarker in the brain predicts future cognitive decline in patients with the language form of Alzheimer’s disease (AD), reports a new Northwestern Medicine study.
The rate of gestational diabetes has shot up 30 percent in young U.S. women over the past decade according to a new Northwestern Medicine study.
A new wearable sensor that actually quantifies itch by measuring scratching when placed on the hand has been developed by Northwestern University scientists.
A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.
An experimental spherical nucleic acid drug developed by Northwestern scientists was able to penetrate the blood-brain barrier and trigger the death of glioblastoma cells.